title: OKT3 induction therapy and cadaveric renal transplantation in black patients.
authors.affiliation: Harper Hospital Renal Transplant Center, Detroit Medical Center, Wayne State University, Detroit, Michigan, USA.
authors.forename: E R
authors.initials: ER
authors.lastname: Reinitz
authors.forename: M P
authors.initials: MP
authors.lastname: Kaplan
authors.forename: D H
authors.initials: DH
authors.lastname: Sillix
authors.forename: K
authors.initials: K
authors.lastname: Lysz
mesh_terms: D000328:Adult; D001741:Black or African American; D001707:Biopsy, Needle; D044383:Black People; D002102:Cadaver; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate; D014019:Tissue Donors
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3